Outbid, Not Outmatched

Why Industrial OEMs Are Losing Deals They Should Be Winning, and When They Cannot Afford To Lose Them

The pattern is familiar to corporate development teams: a bolt-on acquisition, a controls business, a power electronics supplier, a niche software platform that would slot directly into an existing electrification or automation portfolio, comes up for sale. The strategic buyer knows the asset better than anyone else in the room and could integrate it, cross-sell it through an existing channel, and scale it faster than any financial sponsor. A private equity firm comes in several turns higher, and the strategic board takes the discipline as a win. Eighteen months later, the same asset resurfaces as a PE-backed platform, competing for the same customers the OEM already serves, executing the exact roadmap the OEM’s own strategy team once proposed and leadership declined to fund.

Two Different Lenses on the Same Asset

How Private Equity Evaluates a Target

PE evaluates a target largely as a standalone financial asset. The core question is what the business can become on its own, given the right capital structure, incentives, and operational rigor. Returns are underwritten against IRR and MOIC targets, a defined hold period, and an assumed exit multiple. PE is generally not paying for synergies. It is paying for the ability to improve the business independently and sell it at a higher multiple later.

How Strategic Buyers Evaluate a Target

Strategic buyers start from a weaker position. Valuations tend to anchor to standalone DCF and trading comps, with synergies bucketed as speculative upside rather than underwritten into the core bid. Strategic bids are frequently built on a backward-looking view of the market, current-state financials and near-term comps, rather than a forward view of where the sector, technology, or customer base is heading over the next three to five years.

The result is a structural mismatch. PE is not necessarily valuing the business correctly in some absolute sense. It is playing a different game with a different cost of capital and a different mandate. Strategics, however, are frequently underpricing the one thing they can do that PE structurally cannot.

Why This Disadvantages Industrial OEMs

• Rigid capital discipline. WACC-based hurdle rates and EPS accretion and dilution tests are built for steady-state capital allocation, not competitive auctions where speed and conviction matter.
• Slower internal process. Multiple layers of approval, corporate development, finance, business-unit sponsors, sometimes the board, mean strategics often cannot move at PE speed even when they want to.
• Fear of the winner’s curse. Public companies in particular are wary of market reaction to a large, premium-priced deal, which pushes bids toward conservatism even when the underlying thesis is sound.
• Unfamiliar asset types. OEMs that have built their acquisition muscle almost entirely on core hardware businesses often lack the internal literacy to evaluate services, digitally enabled offerings, or other adjacent asset types on their own terms, which compounds the disadvantage well beyond hurdle rates and approval layers. The result is often hesitation, or an under-informed bid, on exactly the kind of target most likely to extend a platform’s relevance.

The net effect is that OEMs frequently self-select out of a deal, or bid low enough to lose, before PE ever has to compete hard for it.

The Case for Synergy-Driven Value

Synergies are real, quantifiable value, not speculative upside to be waved at in an appendix.

• Cost synergies come from redundant overhead, consolidated supply chains, and shared facilities and back-office functions. Announced cost synergies have historically averaged about 16 percent of a target’s cost base[1], and successful integrators realize the large majority of what they announce.
• Revenue synergies come from cross-selling into an existing customer base, channel access, product bundling, and geographic expansion through existing infrastructure. Companies typically fall short of revenue-synergy targets by an average gap of 23 percent, and realization can take roughly five years rather than the two years typical for cost synergies[2].

PE generally cannot access this kind of value unless it is executing a buy-and-build platform strategy, and even then, integrating into a fund-owned platform is a fundamentally different and often harder exercise than integrating into an established operating company with existing systems, culture, and go-to-market motion. An OEM that successfully integrates a target can generate a return profile PE structurally cannot replicate: embedded distribution, brand equity, R&D leverage, and the ability to retain talent inside a mission larger than the deal itself.

The gap between good and poor execution is large and well documented. Companies with successful integrations realize over 83 percent of anticipated synergies, versus less than 47 percent for less-successful acquirers[3]. The implication is direct: if synergies are real value, they belong in the base-case bid, not the sensitivity analysis a deal team quietly ignores.

This is not a hypothetical advantage. Sales to corporate buyers grew 66 percent year over year in 2025[4], evidence that strategic buyers are already converting this advantage into closed deals more often than they were two years ago.

The Scarcity Trap PE Can't See Its Way Out Of

That consolidation curve is playing out nowhere more sharply than in data center power infrastructure itself, the exact category many industrial OEMs are trying to build platforms in. U.S. data center power demand is projected to reach 35 to 45 gigawatts by 2030, roughly double 2024 levels[5], and McKinsey has projected data center-related demand could reach $7 trillion by 2030[6]. That is a genuine, generational strategic opportunity, which is precisely why PE has flooded into the same assets an OEM needs for its own roadmap. The urgency is real on both sides. The difference is that only one side is underwriting it with a synergy case the other cannot replicate.

This is not a reason for OEMs to relax. PE keeps winning these auctions anyway, deployment pressure and speed still give sponsors a real edge independent of price discipline. But as "The Scarcity Premium" details, that discipline is under real strain: hold periods are stretching and overpriced assumptions are failing to materialize. An OEM with a genuine synergy case is not competing against a buyer with better information. It's competing against a buyer whose own math is increasingly unsound.

When the Field Narrows to One or Two

Standard valuation discipline assumes a liquid market with multiple comparable alternatives. That assumption breaks down at the tail end of consolidation. When a defined strategic need, a specific technology, customer base, geography, or capability, narrows to one or two credible targets, the relevant cost is no longer the premium paid over a comp set. It is the cost of not owning the asset.

If a competitor or a PE platform acquires the last credible entry point into a capability an OEM’s strategy depends on, the OEM has not saved money. It has ceded a structural position it may not get another chance to buy. A strategic buyer facing this scenario should treat the decision differently from a routine acquisition, because the alternative to paying up is not a lower price later. It is not having the option at all.

This is not a license to overpay broadly, and discipline still matters in the earlier waves of a consolidating market, when multiple credible targets exist and price competition can be won on fundamentals. The point is narrower: OEMs need a mechanism for recognizing when a market has crossed from competitive to scarce, and for adjusting valuation logic accordingly once it has.

What Industrial OEMs Should Do Differently

1. Revisit valuation methodology. Build synergy capture into the base-case bid, not the sensitivity table. Use separate hurdle rates for acquisitions versus organic growth, and layer in real options, competitive denial, and platform value alongside traditional DCF where appropriate.
2. Get smarter about market forecasting. Replace backward-looking comps with forward-looking sector modeling, what will the target be worth in three to five years, not today. Build a real corporate development function, so decisions don't run on stale data or generic banker decks.
3. Build a truthful view of where synergy actually exists. Assess how the acquisition improves your offering, expands share of wallet, or wins new customers, using real customer purchase criteria, not assumptions.
4. Move faster and remove internal friction. Pre-approve deal theses and valuation bands before a process launches, and give deal teams wider authority so they aren't structurally slower than sponsors by design.
5. Compete on more than price. Certainty of close, cultural continuity, and long-term strategic fit matter to sellers who care about more than the top-line number, especially founder-led businesses.
6. Watch for PE’s own overreach as a signal. A vertical where sponsors are paying platform multiples for average assets and stretching hold periods is one where discipline may be about to reassert itself, often signals the moment to move, not retreat.
7. Build a scarcity trigger into governance. Track credible targets remaining for each priority gap. Once that count drops to one or two, shift from comp-anchored to opportunity-cost pricing, with pre-cleared authority to bid past the normal hurdle rate.
8. Size integration risk by scale, not synergy case alone. Larger deals can be held at arm's length long enough to preserve what made them valuable; smaller bolt-ons carry more integration risk with less structure to absorb them into. Match the approach to scale, not one playbook for every deal. 
   
   
   

   5 Questions Every Strategic Buyer Should Ask Are we underwriting synergies as core value, or as a footnote we will quietly ignore if the board pushes back? Is our valuation built on where the market is today, or where it will be three to five years from now? Are we in this process because it is the right target, or because it is the target that happened to come to us? If this is one of the last one or two credible options against a defined strategic need, does our valuation approach reflect that, or is it still priced as if ten alternatives exist? Do we have the internal capability to evaluate this specific type of asset, or are we learning on the fly during a live deal?

   
   
   

Reframing the Competition

The point is not that OEMs should outbid PE dollar for dollar on every asset. Plenty of deals genuinely are not worth what a sponsor is willing to pay, and discipline still matters. The point is that many OEMs have been underpricing their own advantage, treating synergy value as a nice-to-have and market foresight as someone else’s job, while PE, operating under a different mandate and real deployment pressure, has been winning deals its own pricing logic increasingly cannot support.

The winners over the next cycle will not be the OEMs who match PE’s price on every deal. They will be the ones who see the deal coming before it becomes a competitive process at all, and who know exactly what a target is worth once integration, synergy, a forward-looking market view, and the real cost of scarcity, are part of the math.

Comparison: PE vs. Industrial OEM Valuation Drivers

How BCE Helps

The hardest question in any acquisition is not what a target is worth in isolation. It is what the target is worth to this portfolio, in this market, at this moment. BCE’s diligence work helps industrial OEMs answer that question: sizing the real opportunity, assessing the market’s trajectory over the next three to five years, and mapping how the target strengthens, duplicates, or gaps against the existing portfolio, so the bid reflects a full picture rather than a standalone model.

Bibliography

[1]McKinsey & Company, “Capturing M&A value: Cost, capital, and revenue synergies,” announced cost synergies have historically averaged about 16% of a target’s cost base. mckinsey.com/.../how-strategic-buyers-can-outperform-financial-investors-by-building-a-synergy-muscle

[2]McKinsey & Company, “Seven rules to crack the code on revenue synergies in M&A”: companies fall short of revenue-synergy goals by an average gap of 23%; realization typically takes about five years versus two years for cost synergies. mckinsey.com/.../seven-rules-to-crack-the-code-on-revenue-synergies-in-ma

[3]PwC, “Success factors in post-merger integration,” as cited in FinanceAlliance: successful integrators realize over 83% of anticipated synergies, versus less than 47% for less-successful acquirers. financealliance.io/risks-of-mergers-and-acquisitions

[4]Bain & Company, “Private Equity Outlook 2026: Gaining Traction,” sales to corporate buyers grew 66% year over year in 2025. bain.com/insights/outlook-gaining-traction-global-private-equity-report-2026

[5]Ropes & Gray, “Data Center Investment in 2026: AI Demand, Power Constraints, and Private Equity Trends”: U.S. data center power demand could reach 35–45 GW by 2030, roughly double 2024 levels. ropesgray.com/.../data-center-investment-in-2026-ai-demand-power-constraints-and-private-equity

[6]McKinsey & Company forecast, as cited in The Middle Market: data center-related demand could reach $7 trillion by 2030, growing at roughly 22% annually. themiddlemarket.com/.../private-equity-leans-into-data-center-development-as-lp-demand-surges